CoChat

The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis

Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., Feudtner, C. · 2005 · Clinical Infectious Diseases

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Candida species are the fourth most common cause of bloodstream infection and are the leading cause of invasive fungal infection among hospitalized patients in the United States. However, the frequency and outcomes attributable to the infection are uncertain. This retrospective study set out to estimate the incidence of candidemia in hospitalized adults and children in the United States and to determine attributable mortality, length of hospital stay, and hospital charges related to candidemia. METHODS: We used the Nationwide Inpatient Sample 2000 for adult patients and the Kids' Inpatient Database 2000 for pediatric patients. We matched candidemia-exposed and candidemia-unexposed patients by the propensity scores for the probability of candidemia exposure, which were derived from patient characteristics. Attributable outcomes were calculated as the differences in estimates of outcomes between propensity score-matched patients with and without candidemia. RESULTS: In the United States in 2000, candidemia was diagnosed in an estimated 1118 hospital admissions of pediatric patients and 8949 hospital admissions of adult patients, yielding a frequency of 43 cases per 100,000 pediatric admissions (95% confidence interval [CI], 35-52 cases per 100,000 pediatric admissions) and 30 cases per 100,000 adult admissions (95% CI, 26-34 cases per 100,000 adult admissions). In pediatric patients, candidemia was associated with a 10.0% increase in mortality (95% CI, 6.2%-13.8%), a mean 21.1-day increase in length of stay (95% CI, 14.4-27.8 days), and a mean increase in total per-patient hospital charges of 92,266 dollars (95% CI, 65,058 dollars-119,474 dollars). In adult patients, candidemia was associated with a 14.5% increase in mortality (95% CI, 12.1%-16.9%), a mean 10.1-day increase in length of stay (95% CI, 8.9-11.3 days), and a mean increase in hospital charges of 39,331 dollars (95% CI, 33,604 dollars-45,602 dollars). CONCLUSION: The impact of candidemia on excess mortality, increased length of stay, and the burden of cost of hospitalization underscores the need for improved means of prevention and treatment of candidemia in adults and children.

Overview

Integrity signals

Registry

Crossref · 10.1086/496922

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Rosamond, 2004, American Journal of Epidemiology, 160, 1137, 10.1093/aje/ · doi:10.1093/aje/ · Paper page

Cited by

See all 784

Metadata

Authors
Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • University of Pennsylvania (US)
  • National Cancer Institute (US)
  • Leonard Davis Institute of Health Economics (US)
Corresponding author
Zaoutis, T. E.
Venue
Clinical Infectious Diseases
Published
2005-11-01
Volume
41
Issue
9
Pages
1232-1239
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2146558016
Cited by
784
References
37
Citations by year
2026: 9 · 2025: 17 · 2024: 24 · 2023: 15 · 2022: 22 · 2021: 38 · 2020: 37 · 2019: 43 · 2018: 36 · 2017: 39 · 2016: 39 · 2015: 46 · 2014: 56 · 2013: 59 · 2012: 53
FWCI
18.98
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Agency for Healthcare Research and Quality (K08 HS00002, U18 HS10399)
  • National Institute of Allergy and Infectious Diseases (1K23AI0629753-01)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
candidemia, invasive fungal infections, Candida species, bloodstream infection, incidence, attributable mortality, length of hospital stay, hospital charges, hospitalized children, hospitalized adults, hospitalized infants, propensity score matching, National Inpatient Sample, Kids' Inpatient Database, health care costs, mortality burden
MeSH terms
Aged, Candidiasis, Child, Child, Preschool, Costs and Cost Analysis, Female, Hospitalization, Humans, Infant, Male, Middle Aged, Retrospective Studies, United States, Cohort Studies, Incidence, Fungemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.